<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The purpose of this study was to investigate the anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> effect and explore the mechanisms of <z:chebi fb="0" ids="41423">celecoxib</z:chebi> (a selective <z:chebi fb="0" ids="50629">cyclooxygenase-2 inhibitor</z:chebi>) combined with <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU) on the treatment of human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in a BALB/C <z:mp ids='MP_0003815'>nude</z:mp> mouse subcutaneous <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Effects of <z:chebi fb="0" ids="41423">celecoxib</z:chebi> combined with 5-FU on the proliferation of xenograft <z:mp ids='MP_0002038'>carcinoma</z:mp> induced by HT-29 were investigated </plain></SENT>
<SENT sid="2" pm="."><plain>The apoptotic cells were detected by electron microscope and TUNEL (terminal deoxynucleotidyl transferase <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling) assay </plain></SENT>
<SENT sid="3" pm="."><plain>Immunohistochemistry and Western blot were used to estimate the expression of <z:chebi fb="0" ids="4056">cytochrome</z:chebi> C, caspase-3 and caspase-9 </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Compared with the control group, treatment groups showed significant inhibition of <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>More apoptotic cells existed after treatment with <z:chebi fb="0" ids="41423">celecoxib</z:chebi> combined with 5-FU </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="4056">Cytochrome</z:chebi> C, caspase-3 and caspase-9 were increased in treated groups, and more obviously in the drug combination group </plain></SENT>
<SENT sid="7" pm="."><plain>Cyclooxygenase-2 (COX-2) were decreased after treatment with <z:chebi fb="0" ids="41423">celecoxib</z:chebi> only or combined with 5-FU </plain></SENT>
<SENT sid="8" pm="."><plain>And the combined group showed a greater decrease </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="41423">Celecoxib</z:chebi> combined with 5-FU could inhibit the growth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in vivo by inducing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and activation of the <z:chebi fb="0" ids="4056">cytochrome</z:chebi> C dependency <z:mpath ids='MPATH_3'>apoptosis</z:mpath> signal pathway </plain></SENT>
<SENT sid="10" pm="."><plain>A decrease of COX-2 and an increase of <z:chebi fb="0" ids="4056">cytochrome</z:chebi> C, caspase-3 and caspase-9 may be involved in this process </plain></SENT>
</text></document>